Your browser doesn't support javascript.
loading
Diverse mutational landscapes in human lymphocytes.
Machado, Heather E; Mitchell, Emily; Øbro, Nina F; Kübler, Kirsten; Davies, Megan; Leongamornlert, Daniel; Cull, Alyssa; Maura, Francesco; Sanders, Mathijs A; Cagan, Alex T J; McDonald, Craig; Belmonte, Miriam; Shepherd, Mairi S; Vieira Braga, Felipe A; Osborne, Robert J; Mahbubani, Krishnaa; Martincorena, Iñigo; Laurenti, Elisa; Green, Anthony R; Getz, Gad; Polak, Paz; Saeb-Parsy, Kourosh; Hodson, Daniel J; Kent, David G; Campbell, Peter J.
Afiliación
  • Machado HE; Wellcome Sanger Institute, Hinxton, UK.
  • Mitchell E; Wellcome Sanger Institute, Hinxton, UK.
  • Øbro NF; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Kübler K; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Davies M; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Leongamornlert D; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Cull A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Maura F; Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.
  • Sanders MA; Harvard Medical School, Boston, MA, USA.
  • Cagan ATJ; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • McDonald C; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Belmonte M; Cambridge Molecular Diagnostics, Milton Road, Cambridge, United Kingdom.
  • Shepherd MS; Wellcome Sanger Institute, Hinxton, UK.
  • Vieira Braga FA; York Biomedical Research Institute, University of York, Wentworth Way, York, United Kingdom.
  • Osborne RJ; Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Mahbubani K; Wellcome Sanger Institute, Hinxton, UK.
  • Martincorena I; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Laurenti E; Wellcome Sanger Institute, Hinxton, UK.
  • Green AR; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Getz G; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Polak P; York Biomedical Research Institute, University of York, Wentworth Way, York, United Kingdom.
  • Saeb-Parsy K; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Hodson DJ; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Kent DG; York Biomedical Research Institute, University of York, Wentworth Way, York, United Kingdom.
  • Campbell PJ; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Nature ; 608(7924): 724-732, 2022 08.
Article en En | MEDLINE | ID: mdl-35948631
The lymphocyte genome is prone to many threats, including programmed mutation during differentiation1, antigen-driven proliferation and residency in diverse microenvironments. Here, after developing protocols for expansion of single-cell lymphocyte cultures, we sequenced whole genomes from 717 normal naive and memory B and T cells and haematopoietic stem cells. All lymphocyte subsets carried more point mutations and structural variants than haematopoietic stem cells, with higher burdens in memory cells than in naive cells, and with T cells accumulating mutations at a higher rate throughout life. Off-target effects of immunological diversification accounted for approximately half of the additional differentiation-associated mutations in lymphocytes. Memory B cells acquired, on average, 18 off-target mutations genome-wide for every on-target IGHV mutation during the germinal centre reaction. Structural variation was 16-fold higher in lymphocytes than in stem cells, with around 15% of deletions being attributable to off-target recombinase-activating gene activity. DNA damage from ultraviolet light exposure and other sporadic mutational processes generated hundreds to thousands of mutations in some memory cells. The mutation burden and signatures of normal B cells were broadly similar to those seen in many B-cell cancers, suggesting that malignant transformation of lymphocytes arises from the same mutational processes that are active across normal ontogeny. The mutational landscape of normal lymphocytes chronicles the off-target effects of programmed genome engineering during immunological diversification and the consequences of differentiation, proliferation and residency in diverse microenvironments.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Mutación Límite: Humans Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Mutación Límite: Humans Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido